Reagents for testing.

Ended Awarded Last action

Contract number
HT009026FG0330011
Awardee
Awarding agency
Obligated
$39,278

Award facts

Contract value 100% obligated
$39,277.62 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Portage, MI 49002, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a BPA call to Phadia US Inc. for reagents for testing, with a ceiling value of $39,277.62, awarded March 13, 2026, and completion by September 30, 2026. The call is firm fixed price with no set-aside. Place of performance is Portage, Michigan. The source does not identify the parent BPA by name or provide additional details on the parent vehicle's scope or contracting office.

Quick answers

Who was awarded contract HT009026FG0330011?

HT009026FG0330011 was awarded to Phadia US Inc. by Defense Health Agency (Department of Defense) on March 13, 2026.

How much is contract HT009026FG0330011 worth?

The government has obligated $39,278 on HT009026FG0330011.

Is contract HT009026FG0330011 an order under another contract?

Yes. HT009026FG0330011 is a BPA call under FA301624A0046, a blanket purchase agreement.

Was contract HT009026FG0330011 competed?

The extent of competition for HT009026FG0330011 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award